It was a volatile end to the week after federal investigators reopened a case into Hillary Clinton's email server. The FBI had found emails pertinent to the case, though did not know whether the material would be significant. Stocks plummeted before rebounding. Crude oil ended with a weekly loss for the first time since mid-September on skepticism over an OPEC deal. Oil held lower despite the first weekly decline in active drilling rigs in the U.S. since June. Regeneron (REGN) fell after the FDA delayed approval for its treatment for rheumatoid arthritis. Officials ruled on a delay after finding manufacturing deficiencies at partner Sanofi's (SNY) facility. Hanesbrands (HBI) surged after providing positive sales guidance for its fourth quarter. The apparel brand anticipates quarterly sales of at least $1.7 billion. That came in above consensus. TheStreet's Keris Lahiff reports from Wall Street.
More from Video
Biogen Bulls Get a Lift From Quant Upgrade and Strengthening Charts
Breaking down an approach to the long side of this biotech stock.
Is Renewable Energy the Defensive Stock Opportunity You're Missing
AMSC CEO discusses that and China challenges.
Takeda Pharmaceutical CEO Talks Big Pharma Trends
One of pharma's biggest CEO's talks M&A action on the exchange.
Real Money Video Wrap: Citi Surges as View of Stability Saves Sentiment
Citi overcame a mixed print to send its stock surging on Monday.
Real Money Video Wrap: Apple Rallies as Services Segment Takes Center Stage
There is a lot of Apple news to chew on Wednesday.
Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation.
If you have questions, please contact us here.